ANAVEX LIFE SCIENCES CORP. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$44.50 million for the 12-month period ending 2025-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$44.50M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$39.20M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$41.20M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$40.00M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-09-30 | -$44.50M 10-K/A · filed 2026-08-28 | |
| 2024-09-30 | -$39.20M 10-K/A · filed 2026-08-28 | |
| 2023-09-30 | -$41.20M 10-K/A · filed 2026-08-28 | |
| 2022-09-30 | -$40.00M 10-K · filed 2023-11-27 | -$40.00M 10-K · filed 2022-11-28 |
| 2021-09-30 | -$28.85M 10-K · filed 2023-11-27 | -$28.85M 10-K · filed 2021-11-24 |
| 2020-09-30 | -$18.10M 10-K · filed 2022-11-28 | |
| 2019-09-30 | -$18.03M 10-K · filed 2020-12-28 | |
| 2018-09-30 | -$14.68M 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |